| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/17/2002 | CN1358851A Novel polypeptide-serine/threonine protein kinase 12.54 and polynucleotide for encoding said polypeptide |
| 07/17/2002 | CN1358850A Novel polypeptide-human phosphatidylinositol 3(PtdIns 3)-kinase 17.6 and polynucleotide for encoding said polypeptide |
| 07/17/2002 | CN1358849A Novel polypeptide-human hexokinase protein 9.02 and polynucleotide for encoding said polypeptide |
| 07/17/2002 | CN1358848A Novel polypeptide-steroid dehydrogenase 19.25 and polynucleotide for encoding said polypeptide |
| 07/17/2002 | CN1358847A Novel polypeptide-glyceraldehyde-3-phosphate dehydrogenase 11.99 and polynucleotide for encoding said polypeptide |
| 07/17/2002 | CN1358846A Novel polypeptide-human short chain dehydrogenase 10.23 the polynucleotide for encoding said polypeptide |
| 07/17/2002 | CN1358844A Novel polypeptide-human glucoprotein glucose base transposase 8.80 and polynucleotide for encoding said polypeptide |
| 07/17/2002 | CN1358723A Novel bicyclic amino-pyrazino ketone compound, its preparation method and medicinal composition having same |
| 07/17/2002 | CN1358541A Application of hepatocyte forming agent self-secretion circulation in diagnosis and treatment of liver cancer |
| 07/17/2002 | CN1087779C Macroencapsulated secretory cells |
| 07/17/2002 | CN1087747C Method for preparing medicine using silkworm produced recombined human thrombocytopoietic factor |
| 07/17/2002 | CN1087746C Method for preparing medicine using silkworm expressed recombined human erythropoietin |
| 07/17/2002 | CA2367825A1 Antithrombin iii for disorders caused by angiogenesis |
| 07/16/2002 | US6420591 Carbamates and compositions thereof, and methods for their use for treating cancer, inflammation, or a viral infection |
| 07/16/2002 | US6420545 Nucleotide sequences coding polypeptide for use in the treatment of preferential viral diseases |
| 07/16/2002 | US6420543 Nucleotide sequences coding preferential polypeptide for use in the treatment of immunological and cell proliferative defects |
| 07/16/2002 | US6420542 Tie ligands |
| 07/16/2002 | US6420532 Binding to human y2 receptors and expression |
| 07/16/2002 | US6420531 Polypeptides prepared by expressing in a host cell a dna code with amino acid sequence |
| 07/16/2002 | US6420526 Genetic engineering |
| 07/16/2002 | US6420525 Human transcription factor ZGCL-1 |
| 07/16/2002 | US6420522 Enzyme inhibitors |
| 07/16/2002 | US6420521 Short gastrointestinal peptides |
| 07/16/2002 | US6420520 Peptides and remedy for bone diseases containing the same as active ingredient |
| 07/16/2002 | US6420518 Insulin-like growth factor agonist molecules |
| 07/16/2002 | US6420481 Impact modified polyamide compositions |
| 07/16/2002 | US6420468 Pre-polymerization, monomer(s) dissolved in water-miscible aprotic organic solvent forming non-solvent mixture of polymer; prophylactic or curative antibiotics or antiseptic agents |
| 07/16/2002 | US6420438 1-amino-7-isoquinoline derivatives as serine protease inhibitors |
| 07/16/2002 | US6420432 Surgical irrigation solution and method for inhibition of pain and inflammation |
| 07/16/2002 | US6420424 CCR-3 receptor antagonists |
| 07/16/2002 | US6420414 Amino derivatives of EM-138 and methods of treating angiogenesis with same |
| 07/16/2002 | US6420412 Eprosartan dihydate and a process for its production and formulation |
| 07/16/2002 | US6420380 Hepatitis C inhibitor tri-peptides |
| 07/16/2002 | US6420374 Pentoxifylline. |
| 07/16/2002 | US6420355 Hydrophilic organic solvent; mixed mono-, di-, and triglyceride or a transesterified and polyethoxylated vegetable oil; a polyoxyethylene-sorbitan-fatty ester surfactant; emulsion preconcentrate for oral administration |
| 07/16/2002 | US6420353 Use of 7 α-substituted steroid to treat neuropsychiatric, immune or endocrine disorders |
| 07/16/2002 | US6420345 Methods and reagents for inhibiting angiogenesis |
| 07/16/2002 | US6420342 Ribose, folic acid, orotic acid |
| 07/16/2002 | US6420340 Homogeneous preparation of protein, e.g. leptin, modified at the n-terminal only by an anhydride, e.g. succinic anhydride, ethylenediaminetetraacetic dianhydride; improved solubility; no inflammation at injection sites |
| 07/16/2002 | US6420339 Site-directed dual pegylation of proteins for improved bioactivity and biocompatibility |
| 07/16/2002 | US6420338 Hepatitis b virus (hbv); hepatocellular carcinoma |
| 07/16/2002 | US6420337 Protein isolated from egg whites and yolks of hyperimmunized animals; amino acid sequence seq id no:1 and 6; upregulation of tumor necrosis factor and interleukins-6 and -1beta; downregulation of transforming growth factor-beta |
| 07/16/2002 | US6420336 Purified antiviral protein, peptide or conjugate encoded by amino acid sequence 90% homologous to seq id no: 2; prophy-lactic or therapeutic inhibition of growth of a virus, such as a retrovirus; human immunodeficiency virus, hiv-1 or hiv-2 |
| 07/16/2002 | US6420335 Cancer therapy; angiostatin or endostatin to sensitize tumor endothelial cells to ionizing radiation |
| 07/16/2002 | US6420188 Screening assay for the identification of inhibitors for macrophage migration inhibitory factor |
| 07/16/2002 | US6420175 Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
| 07/16/2002 | US6420161 Nucleotide sequences coding enzymatic polypeptide for use in screening bactericides |
| 07/16/2002 | US6420157 Expression vector coding enzymatic polypeptide for use in the treatment of inflammation and sexual disorders; for use in laundry detergents |
| 07/16/2002 | US6420156 Purified proteolytic enzyme and method of purification |
| 07/16/2002 | US6420155 Polypeptide for use in the treatment of cancer and atherosclerosis |
| 07/16/2002 | US6420154 Mammalian adhesion protease peptides |
| 07/16/2002 | US6420150 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 07/16/2002 | US6420141 Anti-HIV immunogens (toxoids), preparation methods and use for preventing and treating aids |
| 07/16/2002 | US6420136 Controlling gene expression and propagation; obtain cell, incubate with modulator, monitor gene expression inhibition and antiproliferative activities |
| 07/16/2002 | US6420135 Streptococcus pneumoniae polynucleotides and sequences |
| 07/16/2002 | US6420120 Use of a polypeptide as cell receptor for adenoviruses |
| 07/16/2002 | US6420119 Diagnosing urogenital disorders; obtain tissue, monitor proteolysis of support tissues, classify urogenital disorders |
| 07/16/2002 | US6420118 Monitoring activity of mutant tumor suppressor protein; obtain sample containing mutant peptide, incubate with wild type cell, monitor tumor suppression activity of cells |
| 07/16/2002 | US6420110 Methods and reagents for isolating biologically active peptides |
| 07/16/2002 | US6419949 Microparticles for drug delivery across mucosa and the blood-brain barrier |
| 07/16/2002 | US6419944 Cytokine antagonists for the treatment of localized disorders |
| 07/16/2002 | US6419934 Administering tumor necrosis factor antagonist |
| 07/16/2002 | US6419933 Genetic engineered polypeptide |
| 07/16/2002 | US6419929 Genetic engineering |
| 07/16/2002 | US6419928 Monoclonal antibodies to transforming growth factor-beta and methods of use |
| 07/16/2002 | US6419927 Method for reducing adverse effects of a human 70kDa mediator which results from endotoxin stimulation of macrophages |
| 07/16/2002 | US6419926 Specific antibodies for use in preparation of pharmaceutical compositions useful in the prevention or treatment of gastritis, gastric ulcers and duodenal ulcers |
| 07/16/2002 | US6419925 Toxoplasma gondii antigens, the preparation thereof and the use thereof |
| 07/16/2002 | US6419924 Prevent membrane formation; antiproliferative agents; antitumor agents |
| 07/16/2002 | US6419923 Filariid nematode cysteine protease proteins, and uses thereof |
| 07/16/2002 | US6419920 Insoluble collagen matrix |
| 07/16/2002 | US6419919 Method for the augmentation of gene expression |
| 07/16/2002 | US6419918 Receptors of chemotactic peptide; leukemia therapy |
| 07/16/2002 | US6419917 Accumulation of eosinophils using polypeptides |
| 07/16/2002 | US6419914 Polymer with pendant acid functional groups; will not degrade in the gastrointestinal tract |
| 07/16/2002 | CA2286296C Inhibitors for urokinase receptor |
| 07/16/2002 | CA2253663C Hgh-rh(1-29)nh2 analogues having antagonistic activity |
| 07/16/2002 | CA2239360C G-csf analog compositions and methods |
| 07/16/2002 | CA2236158C Method for treating retinal ganglion cell injury using glial cell line-derived neurotrophic factor (gdnf) protein product |
| 07/16/2002 | CA2165521C Topical composition containing a p substance antagonist |
| 07/16/2002 | CA2165519C P substance antagonist used for the treatment of itching, ocular and/or palpebral algia and ocular and/or palpebral dysesthesia |
| 07/16/2002 | CA2165518C P substance antagonist used for the treatment of neurogenous skin redness |
| 07/16/2002 | CA2148537C Stable freeze-dried formulation comprising a protein; assay kit |
| 07/16/2002 | CA2131383C Wound healing and treatment of fibrotic disorders |
| 07/16/2002 | CA2095926C Anti-human milk fat globule humanised antibodies |
| 07/16/2002 | CA2090009C Methods for inhibiting rejection of transplanted tissue |
| 07/16/2002 | CA1341377C Composition and method for acceleration of clot lysis |
| 07/16/2002 | CA1341376C Protein concentrate, method of making and method of using for therapeutic purposes, which forms a clot upon interacting with trombin |
| 07/11/2002 | WO2002054080A2 Proteins, genes and their use for diagnosis and treatment of vascular response |
| 07/11/2002 | WO2002053775A2 Identification of genetic determinants of polymorphic cyp3a5 expression |
| 07/11/2002 | WO2002053770A2 Method for the prediction of the risk potential for cancerous diseases and inflammatory intestinal diseases and corresponding tests |
| 07/11/2002 | WO2002053765A1 Novel molecules of the card-related protein family and used thereof |
| 07/11/2002 | WO2002053760A2 Chimeric cytolytic viruses for cancer treatment |
| 07/11/2002 | WO2002053756A2 Regulation of human glucosamine-6-phosphate deaminase |
| 07/11/2002 | WO2002053755A2 Regulation of human otu-like cysteine protease |
| 07/11/2002 | WO2002053753A2 Novel human lipase and polynucleotides encoding the same |
| 07/11/2002 | WO2002053752A2 Isolated human phosphatase proteins, nucleic acid molecules encoding human phosphatase proteins, and uses thereof |
| 07/11/2002 | WO2002053749A2 Regulation of human serine-threonine protein kinase |
| 07/11/2002 | WO2002053748A1 Regulation of human 3-ss-hydroxysteroid dehydrogenase-isomerase |
| 07/11/2002 | WO2002053743A2 Mammalian tribbles signaling pathways and methods and reagents related thereto |